Biomarker landscape in advanced NSCLC: insights from a national prospective registry
Por:
Provencio, M, Cobo, M, Rodriguez-Abreu, D, Carcereny, E, Calvo, V, Castro, RL, Bernabé, R, Bruno, MF, Bosch-Barrera, J, del Barco, E, Medina, K, Sanchez-Hernandez, A, Suay, G, Ortega, AL, Vázquez, S, Lazaro-Quintela, M, Guirado, M, Estival, A, Blanco, M, Cantero, A and Massutí, B
Publicada:
1 sep 2025
Ahead of Print:
1 jul 2025
Resumen:
Objectives: The determination of actionable genes is a necessity in lung cancer for proper care practice. The Spanish Lung Cancer Group (Fundacion GECP) has performed an exploratory analysis of this aspect, specifically in stage IV non-small cell lung cancer (NSCLC).
Materials and methods: The Thoracic Tumor Registry (TTR) is a Spanish prospective, observational cohort study. At the time of data extraction (March 2024), 27,399 patients were enrolled from 82 hospitals.
Results: There were 13,583 patients with stage IV NSCLC. The analysis of at least one tumor marker was performed in 85.7 % of non-squamous and 62.8 % of squamous patients (p-value < 0.001), with differences between autonomous communities. In the non-squamous population, the three most frequently analysed markers were EGFR (77.3 %), ALK (66.1 %) and PD-L1 (56.3 %). Biomarker profiling has undergone a more pronounced and extensive development in squamous histology in recent years. Molecular determinations that do not have a generally approved targeted therapy have also increased. Biomarker testing in patients with ECOG PS 2 is lower compared to ECOG PS < 2 (77.6 % vs 82.6 %, p-value < 0.001). Sub-analysis shows rates also vary by hospital size.
Conclusion: The analysis of tumor markers in stage IV NSCLC patients continues to increase in Spain, at the same level as in Europe o USA, despite the absence of national plans. There are clinically guided determinations that are rare in squamous histology but have an appreciable percentage of positivity. Even in patients with ECOG PS2, biomarker testing with high clinical suspicion should be considered.
Filiaciones:
Provencio, M:
Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Cobo, M:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Reg & Virgen Victoria Univ Hosp, IBIMA, Med Oncol Interctr Unit, Malaga, Spain
Rodriguez-Abreu, D:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Badalona Germans Trias & Pujol, IGTP, B ARGO, Catalan Inst Oncol, Barcelona, Spain
Calvo, V:
Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Castro, RL:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Clin Univ Valladolid, Valladolid, Spain
Bernabé, R:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Virgen Rocio, Seville, Spain
Bruno, MF:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Complejo Hosp Univ A Coruna, La Coruna, Spain
Bosch-Barrera, J:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Dr Josep Trueta, Inst Catala Oncol, Girona, Spain
Inst Invest Med Girona IDIBGI, Precis Oncol Grp OncoGIR Pro, Girona, Spain
del Barco, E:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Salamanca IBSAL, Salamanca, Spain
Medina, K:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Nuestra Senora Candelaria, Santa Cruz de Tenerife, Spain
Sanchez-Hernandez, A:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain
Suay, G:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ & Politecn La Fe, Valencia, Spain
Ortega, AL:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Jaen, Jaen, Spain
Vázquez, S:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Lucus Augusti, Lugo, Spain
Lazaro-Quintela, M:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Complexo Hosp Univ Vigo, Vigo, Spain
Guirado, M:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Gen Univ Elche, Alicante, Spain
Estival, A:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
Blanco, M:
Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Cantero, A:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Reg & Virgen Victoria Univ Hosp, IBIMA, Med Oncol Interctr Unit, Malaga, Spain
Massutí, B:
Spanish Lung Canc Grp Fdn GECP, Barcelona, Spain
Hosp Gen Univ Dr Balmis Alicante, Alicante, Spain
|